Host defence against disseminated Candida albicans infection and implications for antifungal immunotherapy

Bibliography

• SZABO I, GUAN L, ROGERS TJ: Modulation of macrophage phagocytic activity by cell wall components of Candida albicans. Cell. Immunol. (1995) 164:182-188.
   PubMed Web of Science ®Google Scholar
• VAN SPRIEL AB, LEUSEN JH, VAN EGMOND M et al.: Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation. Blood (2001) 97:2478-2486.
   PubMed Web of Science ®Google Scholar
• BROWN GD, HERRE J, WILLIAMS DL et al.: Dectin-1 mediates the biological effects of beta-glucans. J. Exp. Med. (2003) 197:1119-1124.
   PubMed Web of Science ®Google Scholar
• GANTNER BN, SIMMONS RM, CANAVERA SJ, AKIRA S, UNDERHILL DM: Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. (2003) 197:1107-1117.
   PubMed Web of Science ®Google Scholar
• CAMBI A, GIJZEN K, DE VRIES JM et al.: The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells. Eur. J. Immunol. (2003) 33:532-538.
   PubMed Web of Science ®Google Scholar
• TAKEDA K, KAISHO T, AKIRA S: Toll-like receptors. Annu. Rev. Immunol. (2003) 21:335-376.
   PubMed Web of Science ®Google Scholar
• TADA H, NEMOTO E, SHIMAUCHI H et al.: Saccharomyces cerevisiae- and Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14- and Toll-like receptor 4-dependent manner. Microbiol. Immunol. (2002) 46:503-512.
   PubMed Web of Science ®Google Scholar
• NETEA MG, GOW NA, MUNRO CA et al.: Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J. Clin. Invest. (2006) 116:1642-1650.
   PubMed Web of Science ®Google Scholar
• NETEA MG, VAN DER GRAAF CA, VONK AG et al.: The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J. Infect. Dis. (2002) 185:1483-1489.
   PubMed Web of Science ®Google Scholar
• JOUAULT T, IBATA-OMBETTA S, TAKEUCHI O et al.: Candida albicans phospholipomannan is sensed through toll-like receptors. J. Infect. Dis. (2003) 188:165-172.
   PubMed Web of Science ®Google Scholar
• VILLAMON E, ROIG P, GIL ML, GOZALBO D: Toll-like receptor 2 mediates prostaglandin E(2) production in murine peritoneal macrophages and splenocytes in response to Candida albicans. Res. Microbiol. (2005) 156:115-118.
   PubMed Web of Science ®Google Scholar
• SURAM S, BROWN GD, GHOSH M et al.: Regulation of cytosolic phospholipase A2 activation and cyclooxygenase 2 expression in macrophages by the beta-glucan receptor. J. Biol. Chem. (2006) 281:5506-5514.
   PubMed Web of Science ®Google Scholar
• NETEA MG, SUTMULLER R, HERMANN C et al.: Toll-like receptor 2 suppresses immunity against Candida albicans through Induction of IL-10 and regulatory T cells. J. Immunol. (2004) 172:3712-3718.
   PubMed Web of Science ®Google Scholar
• MONTAGNOLI C, BACCI A, BOZZA S et al.: B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J. Immunol. (2002) 169:6298-6308.
   PubMed Web of Science ®Google Scholar
• VAN DER GRAAF CA, NETEA MG, VERSCHUEREN I, VAN DER MEER JW, KULLBERG BJ: Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae. Infect. Immun. (2005) 73:7458-7464.
   PubMed Web of Science ®Google Scholar
• GANTNER BN, SIMMONS RM, UNDERHILL DM: Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J. (2005) 24:1277-1286.
   PubMed Web of Science ®Google Scholar
• NETEA MG, VAN DER GRAAF C, VAN DER MEER JW, KULLBERG BJ: Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system. J. Leukoc. Biol. (2004) 75:749-755.
   PubMed Web of Science ®Google Scholar
• FILLER SG, SWERDLOFF JN, HOBBS C, LUCKETT PM: Penetration and damage of endothelial cells by Candida albicans. Infect. Immun. (1995) 63:976-983.
   PubMed Web of Science ®Google Scholar
• PHAN QT, FRATTI RA, PRASADARAO NV, EDWARDS JE JR, FILLER SG: N-cadherin mediates endocytosis of Candida albicans by endothelial cells. J. Biol. Chem. (2005) 280:10455-10461.
   PubMed Web of Science ®Google Scholar
• ZINK S, NASS T, ROSEN P, ERNST JF: Migration of the fungal pathogen Candida albicans across endothelial monolayers. Infect. Immun. (1996) 64:5085-5091.
   PubMed Web of Science ®Google Scholar
• PHAN QT, BELANGER PH, FILLER SG: Role of hyphal formation in interactions of Candida albicans with endothelial cells. Infect. Immun. (2000) 68:3485-3490.
   PubMed Web of Science ®Google Scholar
• SANCHEZ AA, JOHNSTON DA, MYERS C et al.: Relationship between Candida albicans virulence during experimental hematogenously disseminated infection and endothelial cell damage in vitro. Infect. Immun. (2004) 72:598-601.
   PubMed Web of Science ®Google Scholar
• IBRAHIM AS, FILLER SG, SANGLARD D, EDWARDS JE JR, HUBE B: Secreted aspartyl proteinases and interactions of Candida albicans with human endothelial cells. Infect. Immun. (1998) 66:3003-3005.
   PubMed Web of Science ®Google Scholar
• KLOTZ SA, MACA RD: Endothelial cell contraction increases Candida adherence to exposed extracellular matrix. Infect. Immun. (1988) 56:2495-2498.
   PubMed Web of Science ®Google Scholar
• KLOTZ SA, HARRISON JL, MISRA RP: Aggregated platelets enhance adherence of Candida yeasts to endothelium. J. Infect. Dis. (1989) 160:669-677.
   PubMed Web of Science ®Google Scholar
• YEAMAN MR, SOLDAN SS, GHANNOUM MA et al.: Resistance to platelet microbicidal protein results in increased severity of experimental Candida albicans endocarditis. Infect. Immun. (1996) 64:1379-1384.
   PubMed Web of Science ®Google Scholar
• FILLER SG, IBE BO, IBRAHIM AS et al.: Mechanisms by which Candida albicans induces endothelial cell prostaglandin synthesis. Infect. Immun. (1994) 62:1064-1069.
   PubMed Web of Science ®Google Scholar
• NOVERR MC, HUFFNAGLE GB: Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect. Immun. (2004) 72:6206-6210.
   PubMed Web of Science ®Google Scholar
• ALEM MA, DOUGLAS LJ: Prostaglandin production during growth of Candida albicans biofilms. J. Med. Microbiol. (2005) 54:1001-1005.
   PubMed Web of Science ®Google Scholar
• ALEM MA, DOUGLAS LJ: Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrob. Agents Chemother. (2004) 48:41-47.
   PubMed Web of Science ®Google Scholar
• NOVERR MC, PHARE SM, TOEWS GB, COFFEY MJ, HUFFNAGLE GB: Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect. Immun. (2001) 69:2957-2963.
   PubMed Web of Science ®Google Scholar
• OROZCO AS, ZHOU X, FILLER SG: Mechanisms of the proinflammatory response of endothelial cells to Candida albicans infection. Infect. Immun. (2000) 68:1134-1141.
   PubMed Web of Science ®Google Scholar
• FILLER SG, PFUNDER AS, SPELLBERG BJ, SPELLBERG JP, EDWARDS JE JR: Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells. Infect. Immun. (1996) 64:2609-2617.
   PubMed Web of Science ®Google Scholar
• ADAMS DH, LLOYD AR: Chemokines: leucocyte recruitment and activation cytokines. Lancet (1997) 349:490-495.
   PubMed Web of Science ®Google Scholar
• BEEKHUIZEN H, VAN FURTH R: Monocyte adherence to human vascular endothelium. J. Leukoc. Biol. (1993) 54:363-378.
   PubMed Web of Science ®Google Scholar
• KULLBERG BJ, VAN ‘T WOUT JW, POELL RJ, VAN FURTH R: Combined effect of fluconazole and recombinant human interleukin- 1 on systemic candidiasis in neutropenic mice. Antimicrob. Agents Chemother. (1992) 36:1225-1229.
   PubMed Web of Science ®Google Scholar
• FULURIJA A, ASHMAN RB, PAPADIMITRIOU JM: Neutrophil depletion increases susceptibility to systemic and vaginal candidiasis in mice, and reveals differences between brain and kidney in mechanisms of host resistance. Microbiology (1996) 142(Pt 12):3487-3496.
   PubMed Web of Science ®Google Scholar
• QIAN Q, JUTILA MA, VAN ROOIJEN N, CUTLER JE: Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J. Immunol. (1994) 152:5000-5008.
   PubMed Web of Science ®Google Scholar
• JENSEN J, WARNER T, BALISH E: The role of phagocytic cells in resistance to disseminated candidiasis in granulocytopenic mice. J. Infect. Dis. (1994) 170:900-905.
   PubMed Web of Science ®Google Scholar
• VAN ‘T WOUT JW, LINDE I, LEIJH PC, VAN FURTH R: Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infection. Eur. J. Clin. Microbiol. Infect. Dis. (1988) 7:736-741.
   PubMed Web of Science ®Google Scholar
• VECCHIARELLI A, BISTONI F, CENCI E, PERITO S, CASSONE A: In-vitro killing of Candida species by murine immunoeffectors and its relationship to the experimental pathogenicity. Sabouraudia (1985) 23:377-387.
   PubMedGoogle Scholar
• BACCARINI M, BLASI E, PUCCETTI P, BISTONI F: Phagocytic killing of Candida albicans by different murine effector cells. Sabouraudia (1983) 21:271-286.
   PubMedGoogle Scholar
• VONK AG, WIELAND CW, NETEA MG, KULLBERG BJ: Phagocytosis and intracellular killing of Candida albicans blastoconidia by neutrophils and macrophages: a comparison of different microbiological test systems. J. Microbiol. Methods (2002) 49:55-62.
   PubMed Web of Science ®Google Scholar
• BRUMMER E, MORRISON CJ, STEVENS DA: Recombinant and natural gamma-interferon activation of macrophages in vitro: different dose requirements for induction of killing activity against phagocytizable and nonphagocytizable fungi. Infect. Immun. (1985) 49:724-730.
   PubMed Web of Science ®Google Scholar
• FERRANTE A: Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release. Infect. Immun. (1989) 57:2115-2122.
   PubMed Web of Science ®Google Scholar
• KULLBERG BJ, VAN ‘T WOUT JW, HOOGSTRATEN C, VAN FURTH R: Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice. J. Infect. Dis. (1993) 168:436-443.
   PubMed Web of Science ®Google Scholar
• DJEU JY, BLANCHARD DK, HALKIAS D, FRIEDMAN H: Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J. Immunol. (1986) 137:2980-2984.
   PubMed Web of Science ®Google Scholar
• YAMAMOTO Y, KLEIN TW, FRIEDMAN H, KIMURA S, YAMAGUCHI H: Granulocyte colony-stimulating factor potentiates anti-Candida albicans growth inhibitory activity of polymorphonuclear cells. FEMS Immunol. Med. Microbiol. (1993) 7:15-22.
   PubMed Web of Science ®Google Scholar
• SCHAFFNER A, DAVIS CE, SCHAFFNER T et al.: In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism. J. Clin. Invest. (1986) 78:511-524.
   PubMed Web of Science ®Google Scholar
• ROILIDES E, HOLMES A, BLAKE C, PIZZO PA, WALSH TJ: Effects of granulocyte colony-stimulating factor and interferon- gamma on antifungal activity of human polymorphonuclear neutrophils against pseudohyphae of different medically important Candida species. J. Leukoc. Biol. (1995) 57:651-656.
   PubMed Web of Science ®Google Scholar
• DIAMOND RD, LYMAN CA, WYSONG DR: Disparate effects of interferon-gamma and tumor necrosis factor- alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro. J. Clin. Invest. (1991) 87:711-720.
   PubMed Web of Science ®Google Scholar
• DIAMOND RD, KRZESICKI R, JAO W: Damage to pseudohyphal forms of Candida albicans by neutrophils in the absence of serum in vitro. J. Clin. Invest. (1978) 61:349-359.
   PubMed Web of Science ®Google Scholar
• DIAMOND RD, KRZESICKI R: Mechansims of attachment of neutrophils to Candida albicans pseudohyphae in the absence of serum, and of subsequent damage to pseudohyphae by microbicidal processes of neutrophils in vitro. J. Clin. Invest. (1978) 61:360-369.
   PubMed Web of Science ®Google Scholar
• DIAMOND RD, CLARK RA, HAUDENSCHILD CC: Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro. J. Clin. Invest. (1980) 66:908-917.
   PubMed Web of Science ®Google Scholar
• LEHRER RI, CLINE MJ: Interaction of Candida albicans with human leukocytes and serum. J. Bacteriol. (1969) 98:996-1004.
   PubMed Web of Science ®Google Scholar
• ASHMAN RB, PAPADIMITRIOU JM: Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol. Rev. (1995) 59:646-672.
   PubMedGoogle Scholar
• DIAMOND RD, HAUDENSCHILD CC: Monocyte-mediated serum-independent damage to hyphal and pseudohyphal forms of Candida albicans in vitro. J. Clin. Invest. (1981) 67:173-182.
   PubMed Web of Science ®Google Scholar
• VAZQUEZ-TORRES A, BALISH E: Macrophages in resistance to candidiasis. Microbiol. Mol. Biol. Rev. (1997) 61:170-192.
   PubMed Web of Science ®Google Scholar
• FANG FC: Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Invest. (1997) 99:2818-2825.
   PubMed Web of Science ®Google Scholar
• MARODI L, FOREHAND JR, JOHNSTON RB JR: Mechanisms of host defense against Candida species. II. Biochemical basis for the killing of Candida by mononuclear phagocytes. J. Immunol. (1991) 146:2790-2794.
   PubMed Web of Science ®Google Scholar
• PRYOR WA, SQUADRITO GL: The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am. J. Physiol. (1995) 268:L699-L722.
   PubMed Web of Science ®Google Scholar
• NETEA MG, MEER JW, VERSCHUEREN I, KULLBERG BJ: CD40/CD40 ligand interactions in the host defense against disseminated Candida albicans infection: the role of macrophage-derived nitric oxide. Eur. J. Immunol. (2002) 32:1455-1463.
   PubMed Web of Science ®Google Scholar
• VAZQUEZ-TORRES A, JONES-CARSON J, WARNER T, BALISH E: Nitric oxide enhances resistance of SCID mice to mucosal candidiasis. J. Infect. Dis. (1995) 172:192-198.
   PubMed Web of Science ®Google Scholar
• VAZQUEZ-TORRES A, JONES-CARSON J, BALISH E: Peroxynitrite contributes to the candidacidal activity of nitric oxide-producing macrophages. Infect. Immun. (1996) 64:3127-3133.
   PubMed Web of Science ®Google Scholar
• ARATANI Y, KOYAMA H, NYUI S et al.: Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect. Immun. (1999) 67:1828-1836.
   PubMed Web of Science ®Google Scholar
• REEVES EP, LU H, JACOBS HL et al.: Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature (2002) 416:291-297.
   PubMed Web of Science ®Google Scholar
• MARKART P, FAUST N, GRAF T et al.: Comparison of the microbicidal and muramidase activities of mouse lysozyme M and P. Biochem. J. (2004) 380:385-392.
   PubMed Web of Science ®Google Scholar
• LUPETTI A, DANESI R, VAN ‘T WOUT JW et al.: Antimicrobial peptides: therapeutic potential for the treatment of Candida infections. Expert. Opin. Investig. Drugs (2002) 11:309-318.
   PubMed Web of Science ®Google Scholar
• NETEA MG, GIJZEN K, COOLEN N et al.: Human dendritic cells are less potent at killing Candida albicans than both monocytes and macrophages. Microbes. Infect. (2004) 6:985-989.
   PubMed Web of Science ®Google Scholar
• D’OSTIANI CF, DEL SERO G, BACCI A et al.: Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J. Exp. Med. (2000) 191:1661-1674.
   Google Scholar
• ROMANI L, BISTONI F, PUCCETTI P: Fungi, dendritic cells and receptors: a host perspective of fungal virulence. Trends Microbiol. (2002) 10:508-514.
   PubMed Web of Science ®Google Scholar
• FORSYTH CB, MATHEWS HL: Lymphocytes utilize CD11b/CD18 for adhesion to Candida albicans. Cell. Immunol. (1996) 170:91-100.
   PubMed Web of Science ®Google Scholar
• BENO DW, STOVER AG, MATHEWS HL: Growth inhibition of Candida albicans hyphae by CD8+ lymphocytes. J. Immunol. (1995) 154:5273-5281.
   PubMed Web of Science ®Google Scholar
• ARANCIA G, MOLINARI A, CRATERI P et al.: Noninhibitory binding of human interleukin-2-activated natural killer cells to the germ tube forms of Candida albicans. Infect. Immun. (1995) 63:280-288.
   PubMed Web of Science ®Google Scholar
• ARANCIA G, STRINGARO A, CRATERI P et al.: Interaction between human interleukin-2-activated natural killer cells and heat-killed germ tube forms of Candida albicans. Cell. Immunol. (1998) 186:28-38.
   PubMed Web of Science ®Google Scholar
• GREENFIELD RA, ABRAMS VL, CRAWFORD DL, KUHLS TL: Effect of abrogation of natural killer cell activity on the course of candidiasis induced by intraperitoneal administration and gastrointestinal candidiasis in mice with severe combined immunodeficiency. Infect. Immun. (1993) 61:2520-2525.
   PubMed Web of Science ®Google Scholar
• ALGARRA I, ORTEGA E, SERRANO MJ, ALVAREZ DC, GAFORIO JJ: Suppression of splenic macrophage Candida albicans phagocytosis following in vivo depletion of natural killer cells in immunocompetent BALB/c mice and T-cell-deficient nude mice. FEMS Immunol. Med. Microbiol. (2002) 33:159-163.
   PubMed Web of Science ®Google Scholar
• MURCIANO C, VILLAMON E, O’CONNOR JE, GOZALBO D, GIL ML: Killed Candida albicans yeasts and hyphae inhibit gamma interferon release by murine natural killer cells. Infect. Immun. (2006) 74:1403-1406.
   PubMed Web of Science ®Google Scholar
• ZHANG MX, CUTLER JE, HAN Y, KOZEL TR: Contrasting roles of mannan-specific monoclonal immunoglobulin M antibodies in the activation of classical and alternative pathways by Candida albicans. Infect. Immun. (1998) 66:6027-6029.
   PubMed Web of Science ®Google Scholar
• KOZEL TR, WEINHOLD LC, LUPAN DM: Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans. Infect. Immun. (1996) 64:3360-3368.
   PubMed Web of Science ®Google Scholar
• NETH O, JACK DL, DODDS AW et al.: Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect. Immun. (2000) 68:688-693.
   PubMed Web of Science ®Google Scholar
• LILLEGARD JB, SIM RB, THORKILDSON P, GATES MA, KOZEL TR: Recognition of Candida albicans by mannan-binding lectin in vitro and in vivo. J. Infect. Dis. (2006) 193:1589-1597.
   PubMed Web of Science ®Google Scholar
• LEE SJ, GONZALEZ-ASEGUINOLAZA G, NUSSENZWEIG MC: Disseminated candidiasis and hepatic malarial infection in mannose-binding-lectin-A-deficient mice. Mol. Cell Biol. (2002) 22:8199-8203.
   PubMed Web of Science ®Google Scholar
• NETEA MG, CURFS JH, DEMACKER PN et al.: Infusion of lipoproteins into volunteers enhances the growth of Candida albicans. Clin. Infect. Dis. (1999) 28:1148-1151.
   PubMed Web of Science ®Google Scholar
• NETEA MG, DEMACKER PN, DE BONT N et al.: Hyperlipoproteinemia enhances susceptibility to acute disseminated Candida albicans infection in low-density-lipoprotein-receptor-deficient mice. Infect. Immun. (1997) 65:2663-2667.
   PubMed Web of Science ®Google Scholar
• D’ANGIO R, QUERCIA RA, TREIBER NK, MCLAUGHLIN JC, KLIMEK JJ: The growth of microorganisms in total parenteral nutrition admixtures. J. Parenter. Enteral. Nutr. (1987) 11:394-397.
   PubMed Web of Science ®Google Scholar
• MURTHY AR, LEHRER RI, HARWIG SS, MIYASAKI KT: In vitro candidastatic properties of the human neutrophil calprotectin complex. J. Immunol. (1993) 151:6291-6301.
   PubMed Web of Science ®Google Scholar
• DE BONT N, NETEA MG, DEMACKER PN et al.: Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae. Eur. J. Clin. Invest. (2000) 30:818-822.
   PubMed Web of Science ®Google Scholar
• VONK AG, DE BONT N, NETEA MG et al.: Apolipoprotein-E-deficient mice exhibit an increased susceptibility to disseminated candidiasis. Med. Mycol. (2004) 42:341-348.
   PubMed Web of Science ®Google Scholar
• MOURAD S, FRIEDMAN H: Pathogenicity of Candida. J. Bacteriol. (1961) 81:550-556.
   PubMed Web of Science ®Google Scholar
• MOURAD S, FRIEDMAN L: Passive immunization of mice against Candida albicans. Sabouraudia (1968) 6:103-105.
   PubMedGoogle Scholar
• CARROW EW, HECTOR RF, DOMER JE: Immunodeficient CBA/N mice respond effectively to Candida albicans. Clin. Immunol. Immunopathol. (1984) 33:371-380.
   PubMedGoogle Scholar
• JENSEN J, WARNER T, BALISH E: Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: role of polymorphonuclear leukocytes and macrophages. J. Infect. Dis. (1993) 167:912-919.
   PubMed Web of Science ®Google Scholar
• HAN Y, CUTLER JE: Antibody response that protects against disseminated candidiasis. Infect. Immun. (1995) 63:2714-2719.
   PubMed Web of Science ®Google Scholar
• HAN Y, RIESSELMAN MH, CUTLER JE: Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody. Infect. Immun. (2000) 68:1649-1654.
   PubMed Web of Science ®Google Scholar
• ZHANG MX, BOHLMAN MC, ITATANI C et al.: Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice. Infect. Immun. (2006) 74:362-369.
   PubMed Web of Science ®Google Scholar
• CAESAR TONTHAT TC, CUTLER JE: A monoclonal antibody to Candida albicans enhances mouse neutrophil candidacidal activity. Infect. Immun. (1997) 65:5354-5357.
   PubMed Web of Science ®Google Scholar
• CUTLER JE: Defining criteria for anti-mannan antibodies to protect against candidiasis. Curr. Mol. Med. (2005) 5:383-392.
   PubMed Web of Science ®Google Scholar
• MATTHEWS RC, BURNIE JP: Human recombinant antibody to HSP90: a natural partner in combination therapy. Curr. Mol. Med. (2005) 5:403-411.
   PubMed Web of Science ®Google Scholar
• VILANOVA M, TEIXEIRA L, CARAMALHO I et al.: Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2. Immunology (2004) 111:334-342.
   PubMed Web of Science ®Google Scholar
• TOROSANTUCCI A, BROMURO C, CHIANI P et al.: A novel glyco-conjugate vaccine against fungal pathogens. J. Exp. Med. (2005) 202:597-606.
   PubMed Web of Science ®Google Scholar
• MONTAGNOLI C, BOZZA S, BACCI A et al.: A role for antibodies in the generation of memory antifungal immunity. Eur. J. Immunol. (2003) 33:1193-1204.
   PubMed Web of Science ®Google Scholar
• ROMANI L, MONTAGNOLI C, BOZZA S et al.: The exploitation of distinct recognition receptors in dendritic cells determines the full range of host immune relationships with Candida albicans. Int. Immunol. (2004) 16:149-161.
   PubMed Web of Science ®Google Scholar
• TRINCHIERI G: Role of interleukin-12 in human Th1 response. Chem. Immunol. (1996) 63:14-29.
   PubMed Web of Science ®Google Scholar
• ROMANI L, MENCACCI A, GROHMANN U et al.: Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J. Exp. Med. (1992) 176:19-25.
   PubMed Web of Science ®Google Scholar
• ROMANI L, PUCCETTI P, MENCACCI A et al.: Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J. Immunol. (1994) 152:3514-3521.
   PubMed Web of Science ®Google Scholar
• VAZQUEZ-TORRES A, JONES-CARSON J, WAGNER RD, WARNER T, BALISH E: Early resistance of interleukin-10 knockout mice to acute systemic candidiasis. Infect. Immun. (1999) 67:670-674.
   PubMed Web of Science ®Google Scholar
• MENCACCI A, DEL SERO G, CENCI E et al.: Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans. J. Exp. Med. (1998) 187:307-317.
   PubMed Web of Science ®Google Scholar
• MENCACCI A, CENCI E, DEL SERO G et al.: IL-10 is required for development of protective Th1 responses in IL-12-deficient mice upon Candida albicans infection. J. Immunol. (1998) 161:6228-6237.
   PubMed Web of Science ®Google Scholar
• SAKAGUCHI S: Regulatory T cells: key controllers of immunologic self-tolerance. Cell (2000) 101:455-458.
   PubMed Web of Science ®Google Scholar
• SHEVACH EM: Certified professionals: CD4(+)CD25(+) suppressor T cells. J. Exp. Med. (2001) 193:F41-F46.
   PubMed Web of Science ®Google Scholar
• RONCAROLO MG, LEVINGS MK: The role of different subsets of T regulatory cells in controlling autoimmunity. Curr. Opin. Immunol. (2000) 12:676-683.
   PubMed Web of Science ®Google Scholar
• COFFMAN RL, VARKILA K, SCOTT P, CHATELAIN R: Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. Immunol. Rev. (1991) 123:189-207.
   PubMed Web of Science ®Google Scholar
• MOORE KW, DE WAAL MR, COFFMAN RL, O’GARRA A: Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. (2001) 19:683-765.
   PubMed Web of Science ®Google Scholar
• HOSKEN NA, SHIBUYA K, HEATH AW, MURPHY KM, O’GARRA A: The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J. Exp. Med. (1995) 182:1579-1584.
   PubMed Web of Science ®Google Scholar
• CUTLER JE: Acute systemic candidiasis in normal and congenitally thymic-deficient (nude) mice. J. Reticuloendothel. Soc. (1976) 19:121-124.
   PubMedGoogle Scholar
• JONES-CARSON J, VAZQUEZ-TORRES A, WARNER T, BALISH E: Disparate requirement for T cells in resistance to mucosal and acute systemic candidiasis. Infect. Immun. (2000) 68:2363-2365.
   PubMed Web of Science ®Google Scholar
• MENCACCI A, SPACCAPELO R, DEL SERO G et al.: CD4+ T-helper-cell responses in mice with low-level Candida albicans infection. Infect. Immun. (1996) 64:4907-4914.
   PubMed Web of Science ®Google Scholar
• SPACCAPELO R, ROMANI L, TONNETTI L et al.: TGF-beta is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans. J. Immunol. (1995) 155:1349-1360.
   PubMed Web of Science ®Google Scholar
• KULLBERG BJ, VAN ‘T WOUT JW, VAN FURTH R: Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1. Infect. Immun. (1990) 58:3319-3324.
   PubMed Web of Science ®Google Scholar
• VAN’T WOUT JW, VAN DER MEER JW, BARZA M, DINARELLO CA: Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin 1. Eur. J. Immunol. (1988) 18:1143-1146.
   PubMed Web of Science ®Google Scholar
• STUYT RJ, NETEA MG, VAN KRIEKEN JH, VAN DER MEER JW, KULLBERG BJ: Recombinant interleukin-18 protects against disseminated Candida albicans infection in mice. J. Infect. Dis. (2004) 189:1524-1527.
   PubMed Web of Science ®Google Scholar
• NETEA MG, VAN TITS LJ, CURFS JH et al.: Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. J. Immunol. (1999) 163:1498-1505.
   PubMed Web of Science ®Google Scholar
• NETEA MG, BROUWER AE, HOOGENDOORN EH et al.: Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia: defective cytokine production and reversal by recombinant interferon-gamma therapy. Clin. Infect. Dis. (2004) 39:e83-e87.
   PubMed Web of Science ®Google Scholar
• KULLBERG BJ, OUDE LASHOF AM, NETEA MG: Design of efficacy trials of cytokines in combination with antifungal drugs. Clin. Infect. Dis. (2004) 39(Suppl. 4):S218-S223.
   Web of Science ®Google Scholar
• KULLBERG BJ, NETEA MG, CURFS JH et al.: Recombinant murine granulocyte colony-stimulating factor protects against acute disseminated Candida albicans infection in nonneutropenic mice. J. Infect. Dis. (1998) 177:175-181.
   PubMed Web of Science ®Google Scholar
• VAN SPRIEL AB, VAN DEN HERIK-OUDIJK IE, VAN DE WINKEL JG: A single injection of polyethylene-glycol granulocyte colony-stimulating factor strongly prolongs survival of mice with systemic candidiasis. Cytokine (2000) 12:666-670.
   PubMed Web of Science ®Google Scholar
• KULLBERG BJ, VANDEWOUDE K, HERBRECHT R, JACOBS F, KUJATH P: A double-blind, randomized, placebo-controlled Phase II study of filgrastim (recombinant granulocyte colony-stimulating factor) in combination with fluconazole for treatment of invasive candidiasis and candidemia in nonneutropenic patients. In: 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society of Microbiology, Washington DC, USA (1998):479.
   Google Scholar
• MENCACCI A, TOROSANTUCCI A, SPACCAPELO R et al.: A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice. Infect. Immun. (1994) 62:5353-5360.
   PubMed Web of Science ®Google Scholar
• HAN Y, ULRICH MA, CUTLER JE: Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis. J. Infect. Dis. (1999) 179:1477-1484.
   PubMed Web of Science ®Google Scholar
• MONTAGNOLI C, SANDINI S, BACCI A, ROMANI L, LA VALLE R: Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis. Med. Mycol. (2004) 42:319-324.
   PubMed Web of Science ®Google Scholar
• IBRAHIM AS, SPELLBERG BJ, AVENISSIAN V et al.: Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity. Infect. Immun. (2005) 73:999-1005.
   PubMed Web of Science ®Google Scholar
• BROMURO C, TOROSANTUCCI A, CHIANI P et al.: Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated candidiasis in recipients of a Candida albicans vaccine. Infect. Immun. (2002) 70:5462-5470.
   PubMed Web of Science ®Google Scholar
• IWASAKI A, MEDZHITOV R: Toll-like receptor control of the adaptive immune responses. Nat. Immunol. (2004) 5:987-995.
   PubMed Web of Science ®Google Scholar
• VILLAMON E, GOZALBO D, ROIG P et al.: Toll-like receptor 2 is dispensable for acquired host immune resistance to Candida albicans in a murine model of disseminated candidiasis. Microbes Infect. (2004) 6:542-548.
   PubMed Web of Science ®Google Scholar
• BELLOCCHIO S, MONTAGNOLI C, BOZZA S et al.: The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J. Immunol. (2004) 172:3059-3069.
   PubMed Web of Science ®Google Scholar
• LIU L, KANG K, TAKAHARA M, COOPER KD, GHANNOUM MA: Hyphae and yeasts of Candida albicans differentially regulate interleukin-12 production by human blood monocytes: inhibitory role of C. albicans germination. Infect. Immun. (2001) 69:4695-4697.
   PubMed Web of Science ®Google Scholar